Abstract
This study aimed to determine the association between proteinuria severity and maternal/neonatal outcomes among preeclamptic women with hypertension with proteinuria. We retrospectively assessed 721 women at 11 institutions. All participants had singleton pregnancies and delivered at ≥22 gestational weeks. They were diagnosed with preeclampsia (excluding superimposed preeclampsia) after 20 gestational weeks and had results from a spot urine protein/creatinine ratio test at delivery. The severe proteinuria significantly increased the frequency of preterm delivery in the both women of severe and nonsevere hypertension (72.3% vs. 49.9%, 57.5% vs. 24.8%, p < 0.001, respectively). In the nonsevere hypertension and severe proteinuria group comparison with the severe hypertension and nonsevere proteinuria group, the frequency of women with pulmonary edema/pleural effusion onset was significantly higher (15.0% vs. 5.8%, p = 0.041) and the median serum albumin was significantly lower (2.6 g/dL vs. 2.8 g/dL, p < 0.001). Furthermore, the serum albumin was the laboratory findings with the highest relationship to u-P/C ratio at delivery. Women with preeclampsia with severe hypoalbuminemia had a significant high risk of developing severe proteinuria and pulmonary edema/pleural effusion at delivery than those without severe hypoalbuminemia, respectively. However, severe hypoalbuminemia was not the risk factor for severe hypertension in women with preeclampsia. Women with preeclampsia with severe proteinuria would have worse maternal outcome (pulmonary edema and/or pleural effusion induced by hypoalbuminemia) than those with severe hypertension. In conclusion, obstetricians should be aware of the risk of maternal pulmonary edema/pleural effusion in cases of preeclampsia with nonsevere hypertension with severe proteinuria.

This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout


Similar content being viewed by others
References
Thangaratinam S, Coomarasamy A, O’Mahony F, Sharp S, Zamora J, Khan KS, et al. Estimation of proteinuria as a predictor of complications of pre-eclampsia: a systematic review. BMC Med. 2009;7:10.
Magee LA, Brown MA, Hall DR, Gupte S, Hennessy A, Karumanchi SA, et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2022;27:148–69.
Fishel Bartal M, Lindheimer MD, Sibai BM. Proteinuria during pregnancy: definition, pathophysiology, methodology, and clinical significance. Am J Obstet Gynecol. 2022;226:S819–34.
Bokuda K. Understanding preeclampsia from cutting edge knowledge-protecting maternal and fetal health. Hypertens Res. 2024;47:3367–71.
Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72:24–43.
Espinoza J, Vidaeff A, Pettker CM, Simhan H. ACOG practice bulletin no. 202: gestational hypertension and preeclampsia. Obstet Gynecol. 2019;133:e1–25.
Guida JP, Parpinelli MA, Surita FG, Costa ML. The impact of proteinuria on maternal and perinatal outcomes among women with pre-eclampsia. Int J Gynaecol Obstet. 2018;143:101–7.
Tanacan A, Fadiloglu E, Beksac MS. The importance of proteinuria in preeclampsia and its predictive role in maternal and neonatal outcomes. Hypertens Pregnancy. 2019;38:111–8.
Paula LG, Pinheiro da Costa BE, Hentschke MR, Antonello IC, Luz JH, da Cunha Filho EV, et al. Increased proteinuria and uric acid levels are associated with eclamptic crisis. Pregnancy Hypertens. 2019;15:93–7.
Xu X, Wang Y, Xu H, Kang Y, Zhu Q. Association between proteinuria and maternal and neonatal outcomes in pre-eclampsia pregnancy: a retrospective observational study. J Int Med Res. 2020;48:300060520908114.
Morikawa M, Mayama M, Saito Y, Nakagawa-Akabane K, Umazume T, Chiba K, et al. Severe proteinuria as a parameter of worse perinatal/neonatal outcomes in women with preeclampsia. Pregnancy Hypertens. 2020;19:119–26.
Lei T, Qiu T, Liao W, Li K, Lai X, Huang H, et al. Proteinuria may be an indicator of adverse pregnancy outcomes in patients with preeclampsia: a retrospective study. Reprod Biol Endocrinol. 2021;19:71.
Hu M, Shi J, Lu W. Association between proteinuria and adverse pregnancy outcomes: a retrospective cohort study. J Obstet Gynaecol. 2023;43:2126299.
Murali A, Rengaraj S, Priyamvada PS, Sivanandan S, Udayakumar KR. Proteinuria in predicting adverse outcomes in women with severe features of pre-eclampsia from a developing country: a prospective cohort study. Int J Gynaecol Obstet. 2024;165:1064–71.
Hendem DU, Oluklu D, Beser DM, Yildirim M, Turgut E, Tanacan A, et al. Evaluation of fetal cardiac functions in preeclampsia: does the severity or proteinuria affect fetal cardiac functions?. J Ultrasound Med. 2023;42:2415–24.
Xiao J, Fan W, Zhu Q, Shi Z. Diagnosis of proteinuria using a random urine protein-creatinine ratio and its correlation with adverse outcomes in pregnancy with preeclampsia characterized by renal damage. J Clin Hypertens. 2022;24:652–9.
Cozzi GD, Battarbee AN, Sanjanwala AR, Casey BM, Subramaniam A. Amount of proteinuria and duration of expectant management in severe preeclampsia. Am J Perinatol. 2024;41:790–7.
Genest DS, Dal Soglio D, Girard S, Rey E. Association between proteinuria and placental pathology in preeclampsia: a retrospective study. SAGE Open Med. 2021;9:20503121211058053.
Watanabe K, Matsubara K, Nakamoto O, Ushijima J, Ohkuchi A, Koide K, et al. Outline of the new definition and classification of “Hypertensive Disorders of Pregnancy (HDP)”; a revised JSSHP statement of 2005. Hypertens Res Pregnancy. 2019;1:1–5.
BMJ Best Practice. Assessment of nephrotic syndrome. 2021. URL: https://bestpractice.bmj.com/topics/en-gb/356.
Itakura A, Shoji S, Shigeru A, Kotaro F, Junichi H, Hironobu H, et al. Guidelines for obstetrical practice in Japan: Japan Society of Obstetrics and Gynecology and Japan Association of Obstetricians and Gynecologists 2020 edition. J Obstet Gynaecol Res. 2023;49:5–53.
Multifetal gestations: twin, triplet, and higher-order multifetal pregnancies: ACOG practice bulletin, number 231. Obstet Gynecol. 2021;137:e145–e162.
Umesawa M, Kobashi G. Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis. Hypertens Res. 2017;40:213–20.
Suzuki Y, Matsubara K, Watanabe K, Tanaka K, Yamamoto T, Nohira T, et al. A multicenter prospective study of home blood pressure measurement (HBPM) during pregnancy in Japanese women. Hypertens Res. 2022;45:1563–74.
Tucker KL, Hinton L, Green M, Chappell LC, McManus RJ. Using self-monitoring to detect and manage raised blood pressure and pre-eclampsia during pregnancy: the BUMP research programme and its impact. Hypertens Res. 2024;47:714–20.
Ekiz A, Kaya B, Polat I, Avci ME, Ozkose B, Kicik Caliskan R, et al. The outcome of pregnancy with new onset proteinuria without hypertension: retrospective observational study. J Matern Fetal Neonatal Med. 2016;29:1765–9.
Eid AA, Keddissi JI, Kinasewitz GT. Hypoalbuminemia as a cause of pleural effusions. Chest. 1999;115:1066–9.
Morikawa M, Mayama M, Saito Y, Akabane-Nakagawa K, Umazume T, Chiba K, et al. Hypoproteinemia as a parameter of poor perinatal/neonatal outcomes in women with preeclampsia diagnosed as hypertension plus proteinuria. Pregnancy Hypertens. 2020;21:111–7.
Lv Y, Zhou Y, Hu R, Liang Y, Lian Y, Wang J, et al. Association between hypoproteinaemia with massive proteinuria and small for gestational age in pre-eclampsia: a single-centre, retrospective cohort study using propensity score matching. BMJ Open. 2023;13:e071835.
Zhai T, Furuta I, Nakagawa K, Kojima T, Umazume T, Ishikawa S, et al. Second-trimester urine nephrin: creatinine ratio versus soluble fms-like tyrosine kinase-1: placental growth factor ratio for prediction of preeclampsia among asymptomatic women. Sci Rep. 2016;6:37442.
Craici IM, Wagner SJ, Weissgerber TL, Grande JP, Garovic VD. Advances in the pathophysiology of pre-eclampsia and related podocyte injury. Kidney Int. 2014;86:275–85.
Kwiatkowska E, Stefańska K, Zieliński M, Sakowska J, Jankowiak M, Trzonkowski P, et al. Podocytes-the most vulnerable renal cells in preeclampsia. Int J Mol Sci. 2020;21:5051.
Fonseca C, Morais H, Mota T, Matias F, Costa C, Gouveia-Oliveira A, et al. The diagnosis of heart failure in primary care: value of symptoms and signs. Eur J Heart Fail. 2004;6:795–800.
Lindheimer MD, Katz AI. Preeclampsia: pathophysiology, diagnosis, and management. Annu Rev Med. 1989;40:233–50.
Benedetti TJ, Kates R, Williams V. Hemodynamic observations in severe preeclampsia complicated by pulmonary edema. Am J Obstet Gynecol. 1985;152:330–4.
Dennis AT, Solnordal CB. Acute pulmonary oedema in pregnant women. Anesthesia. 2012;67:646–59.
Espeche W, Minetto J, Salazar MR. Utility of 24-hour ambulatory monitoring and the Sflt-1/PlGF ratio in preeclampsia prediction. Hypertens Res. 2024;47:1436–7.
Acknowledgements
The authors thank the Japan Society for the Study of Hypertension in Pregnancy (JSSHP). In particular, we thank Dr. Manabu Ogoyama (Jichi Medical University) and Tomohito Okamoto (Aichi Medical University) for their support with data collection. The authors thank Enago (www.enago.jp) for the English language review.
Funding
MM received funding for this work from the Japan Society for the Study of Hypertension in Pregnancy (JSSHP).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Morikawa, M., Ohkuchi, A., Iriyama, T. et al. Clinical significance of severe proteinuria in preeclampsia: a multicenter study of maternal and neonatal outcomes. Hypertens Res 48, 2991–3008 (2025). https://doi.org/10.1038/s41440-025-02360-3
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41440-025-02360-3


